Tanım

DNA vaccines are third-generation vaccines. They contain DNA that codes for specific proteins (antigens) from a pathogen. DNA vaccines have emerged as a safer alternative to standard live and inactivated vaccines for treating human and animal viral diseases. They exhibit several advantages over traditional strategies in terms of safety, stability, ease of manufacturing, and immunogenicity. The global DNA vaccines market is poised to grow by US$ 14,948.0 milyon itibaren 2022 ile 2028, CAGR'nin kaydedilmesi 30.1% tahmin dönemi boyunca, StratejiHelix'e göre.

Rapor, döneme ilişkin güncel pazar büyüklüğü verilerini sağlar 2018-2021 ve tahmin 2028 covering key market aspects like sales value for DNA vaccines. The global DNA vaccines market is segmented on the basis of type, başvuru, and end user. Türe göre, the global DNA vaccines market has been segmented into clinical applications, research tools. The research tools segment was the largest contributor to the global DNA vaccines market in 2021. Based upon application, the global DNA vaccines market is categorized into genetic immunization, pDNA formulations. According to the research, the genetic immunization segment had the largest share in the global DNA vaccines market. On the basis of end user, the global DNA vaccines market has been segmented into animal health, biodefense, cancers, infectious diseases, diğerleri. The cancers segment held the largest revenue share in 2021.

The global DNA vaccines market is highly competitive. Some of the leading companies operating in the market are Astellas Pharma Inc., AstraZeneca plc, Bristol Myers Squibb Company (BMS), Gilead Sciences Inc., Johnson & Johnson, Merck KGaA, Novartis International AG, Pfizer Inc., Sanofi SA.

Rapor, bu sektörde faaliyet gösteren şirket ve kuruluşlar için paha biçilmez bir kaynaktır. It provides a cohesive picture of the DNA vaccines market to help drive informed decision making for industry executives, kural koyucular, akademik, ve analistler.

Rapor Kapsamı

Tip: clinical applications, research tools
Başvuru: genetic immunization, pDNA formulations
End user: animal health, biodefense, cancers, infectious diseases, diğerleri
Dikkate alınan yıllar: bu rapor dönemi kapsamaktadır 2018 ile 2028

Paydaşlar için Temel Faydalar

– Get a comprehensive picture of the global DNA vaccines market
– Yerel verilere dayanarak bölgesel stratejiler ve stratejik önceliklerin belirlenmesi
– Büyüme sektörlerini ve yatırım eğilimlerini belirleyin

İçindekiler

Parça 1. giriiş
– Çalışmanın kapsamı
– Çalışma periyodu
– Coğrafik kapsam
– Araştırma metodolojisi
Parça 2. DNA vaccines market overview
Parça 3. Market breakdown by type
– Clinical applications
– Research tools
Parça 4. Market breakdown by application
– Genetic immunization
– PDNA formulations
Parça 5. Market breakdown by end user
– Animal health
– Biodefense
– Cancers
– Infectious diseases
– Diğerleri
Parça 6. Anahtar şirketler
– Astellas Pharma Inc.
– AstraZeneca plc
– Bristol Myers Squibb Company (BMS)
– Gilead Sciences, A.Ş..
– Johnson & Johnson
– Merck KGaA
– Novartis International AG
– Pfizer Inc.
– Sanofi SA.
StratejiHelix Hakkında
Sorumluluk reddi beyanı